Skip to content

Abbott ABT Price / book

Price / book at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
1.9×-0.8×
Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Boston Scientific logo
Boston ScientificBSX
3.6×-3.1×
DexCom logo
DexComDXCM
8.2×-3.6×
Edwards Lifesciences logo
Edwards LifesciencesEW
4.5×+0.3×
Medtronic logo
MedtronicMDT
2.1×-0.1×

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Calculated from Abbott’s reported figures.

Based on the most recent quarter.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's price / book?
Abbott (ABT) reported price / book of 3.4× in Q1 2026.
How has Abbott's price / book changed year-over-year?
Abbott's price / book decreased by 27.3% year-over-year, from 4.7× to 3.4×.
What is the long-term trend for Abbott's price / book?
Over 4 years (2021 to 2025), Abbott's price / book has grown at a -8.0% compound annual growth rate (CAGR), from 25.4× to 18.2×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.